Which of the following is a precaution associated with ipratropium bromide use?

Prepare for emergency medicine exams with our comprehensive test. Explore multiple choice questions, receive hints and explanations. Sharpen your knowledge and ensure success!

Multiple Choice

Which of the following is a precaution associated with ipratropium bromide use?

Explanation:
Ipra­tropium bromide is an inhaled anticholinergic bronchodilator that blocks muscarinic receptors in airway smooth muscle to reduce bronchoconstriction. Because some systemic absorption can occur, its anticholinergic effects can affect other tissues as well. In people with narrow-angle glaucoma, anticholinergic drugs can cause pupil dilation that may narrow the angle and trigger acute angle-closure glaucoma, so ipratropium should be used with caution in these patients. This is the key precaution: avoid or monitor closely in narrow-angle glaucoma. The other statements aren’t correct because ipratropium is not categorically contraindicated in pregnancy, it is commonly used with albuterol (there are inhalers and nebulations combining the two), and there isn’t a problematic interaction that would require avoiding concurrent use.

Ipra­tropium bromide is an inhaled anticholinergic bronchodilator that blocks muscarinic receptors in airway smooth muscle to reduce bronchoconstriction. Because some systemic absorption can occur, its anticholinergic effects can affect other tissues as well. In people with narrow-angle glaucoma, anticholinergic drugs can cause pupil dilation that may narrow the angle and trigger acute angle-closure glaucoma, so ipratropium should be used with caution in these patients. This is the key precaution: avoid or monitor closely in narrow-angle glaucoma.

The other statements aren’t correct because ipratropium is not categorically contraindicated in pregnancy, it is commonly used with albuterol (there are inhalers and nebulations combining the two), and there isn’t a problematic interaction that would require avoiding concurrent use.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy